H.C. Wainwright said 'Ignore the Noise' on Capricor Therapeutics (CAPR) and Buy
Tweet Send to a Friend
H.C. Wainwright analyst Joseph Pantginis reiterated a Buy rating and $77.00 price target on Capricor Therapeutics (NASDAQ: CAPR), telling clients ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
